FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.7120
-0.0235 (-3.20%)
At close: Jul 24, 2026, 4:00 PM EDT
0.7450
+0.0330 (4.63%)
After-hours: Jul 24, 2026, 7:45 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $3.84 million as of July 24, 2026. Its market cap has decreased by -85.20% in one year.
Market Cap
3.84M
Enterprise Value
4.84M
1-Year Change
-85.20%
Ranking
Category
Stock Price
$0.71
ChartMarket Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $3.84M, a decrease of -99.59%. That is a compound annual growth rate of -89.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.84M | -74.30% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 4.43M |
| PMGC Holdings | 4.36M |
| Revelation Biosciences | 4.14M |
| 60 Degrees Pharmaceuticals | 4.12M |
| Ensysce Biosciences | 4.05M |
| Artelo Biosciences | 3.69M |
| Galmed Pharmaceuticals | 3.50M |
| HCW Biologics | 3.50M |